Strata Critical Medical, Inc. Q1 2026 Earnings Recap

Strata’s shares rallied 10.8% following a quarter marked by robust revenue growth driven by Logistics and new Clinical business lines, alongside positive signs of improving cash flow and an active M&A pipeline that exceeded investor expectations.

Key Takeaways

• Reported 87% year-over-year revenue growth, led by 32% organic growth in Logistics and strong contributions from the new Clinical segment.
• Generated operating and free cash flow before aircraft acquisitions for the first time this quarter, indicating improved earnings quality.
• Announced a new acquisition of Ohio Valley Perfusion Associates, aligned with a broader M&A strategy targeting fragmented markets with mid-single-digit EBITDA multiples.
• Expanded logistics footprint with a new base in Chicago and a total fleet of 10 owned aircraft plus 35 dedicated, enhancing national service coverage.
• Industry trends toward increased adoption of NRP and third-party surgical recovery have offset declines in donor volume, supporting demand for Strata’s integrated platform.